Effect of the breast-cancer resistance protein on atypical multidrug resistance.
about
The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by Nrf2 silencingSynthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance proteinKinetic Modeling of ABCG2 Transporter Heterogeneity: A Quantitative, Single-Cell Analysis of the Side Population Assay.Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survivalIntegrins and extracellular matrix: a novel mechanism of multidrug resistance.Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.Induction of the ABC-transporters Mdr1/P-gp (Abcb1), mrpl (Abcc1), and bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone.Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60.Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2).Association of genomic imbalances with drug resistance and thermoresistance in human gastric carcinoma cells.Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone.Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain.
P2860
Q28543003-4DF2AB96-DBC1-4F1D-88E5-03A5D9F29C46Q30439828-E9A794F9-1E73-4BE6-A84B-F196087E8233Q32186144-9E67FF2A-0C6A-4BB1-A1F3-BD78E92B8261Q34449010-53B34DDD-09DD-46B7-95A2-41856A581932Q35089143-EF5E00C1-3C4A-4CA5-83DC-3E7486D3561CQ38291790-49F8D9E6-72D5-4D42-AB17-35856FB69168Q40416245-5965797F-7E5A-4F75-9D85-BF2B4A232AE9Q40629458-F3667AA1-0B13-41C1-9ABF-AB08AF3013BEQ40639410-0D456F85-9B9E-459E-A0EB-C9A95F18A2BCQ40679168-8AC4F89E-5912-4C7A-914C-973FFFF3F686Q40722578-92668F6E-46AC-4865-8E48-102751788C3CQ40785068-7DE95BC1-3143-4E67-946A-158FE495D700Q41921173-B0027920-D310-4819-9C55-758EA8609786Q46536800-B100E820-1039-41E1-BD36-B87CDF1C200F
P2860
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
@ast
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
@en
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
@nl
type
label
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
@ast
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
@en
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
@nl
prefLabel
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
@ast
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
@en
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
@nl
P1433
P1476
Effect of the breast-cancer resistance protein on atypical multidrug resistance.
@en
P304
P356
10.1016/S1470-2045(00)00032-2
P577
2000-11-01T00:00:00Z